Results 211 to 220 of about 623,254 (248)

Making Value‐Chain Risks Visible: Extending ENCORE for Systemic Insights

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Businesses in all sectors, including downstream segments, depend on biodiversity and the ecosystem services it sustains, yet firms also exert pressures that accelerate biodiversity loss. The latter generates material risks for both companies and their financial stakeholders.
Hjalmar Funke   +3 more
wiley   +1 more source

Using Machine Learning to Predict Corporate Environmental Violation: A Stakeholder Pressure Perspective

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Predicting corporate environmental violations remains a key challenge in practice and in environmental governance research. However, existing studies have largely focused on ex post associations between stakeholder pressures and realized environmental violations, offering limited insight into whether stakeholder pressures can be used ex ante ...
Xiaolan Chen   +4 more
wiley   +1 more source

How Circular Innovation Is Learned: A Process Study of Modularity‐Based Initiatives in Industrial Firms

open access: yesBusiness Strategy and the Environment, EarlyView.
ABSTRACT Circular innovation (CI) research has identified a wide range of circular strategies and design approaches, yet offers limited insight into how CI evolves as a learning process within firms and which governance mechanisms guide this progression. Drawing on organizational learning (OL), this study examines how exploration and exploitation shape
Shamima Haque   +2 more
wiley   +1 more source

Vascular atrophy of the optic nerve

open access: yesIndian Journal of Ophthalmology, 1958
Gupta S, Singh Ram
doaj  

Intrathecal Plasma Cell Activity as Measured by the Kappa Free Light Chain Index Is Associated With Retinal Layer Atrophy in Early Multiple Sclerosis. [PDF]

open access: yesEur J Neurol
Berek K   +19 more
europepmc   +1 more source

Status and future of recombinant adeno‐associated virus vector manufacturing

open access: yesBiotechnology Progress, EarlyView.
Abstract Sixty years of adeno‐associated virus (AAV) research illustrates a trajectory marked by basic science exploration, iterative innovation, persistent challenges, a number of clinical setbacks, as well as commercial therapeutic triumphs. This continual evolution has led to recombinant AAV (rAAV) becoming a cornerstone of modern gene therapy ...
Frank Agbogbo, David Dismuke
wiley   +1 more source

Phenotypic Variations in a Large Family with Dominant Optic Atrophy Related to a Novel <i>OPA1</i> Deletion. [PDF]

open access: yesOphthalmol Sci
Bouzidi A   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy